Limax prior to radioembolization for hepatocellular carcinoma as an additional tool for patient selection in patients with liver cirrhosis

HIGHLIGHTS

  • who: Catherine Leyh et al. from the Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, Essen, Germany have published the research work: LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis, in the Journal: (JOURNAL)
  • how: For the correlation analysis the authors used Spearman`s rank correlation coefficient or Pearson correlation coefficient depending on whether the data were normally distributed or not.

SUMMARY

    Of 14 4 of 14 RE was performed using standard protocols. Briefly, after baseline angiography for . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?